One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1016/j.clml.2017.07.105
Copy DOI Journal: Clinical Lymphoma & Myeloma |  Publication Date: Sep 1, 2017 |
 Citations: 1 |
Affiliation: Hôpital Lyon Sud, Takeda (United States), University of Bologna, Moffitt Cancer Center, South Australian Health and Medical Research Institute, University of Adelaide, Cedars-Sinai Medical Center, Jena University Hospital, Charité - Universitätsmedizin Berlin, Huntsman Cancer Institute, University of Utah, Singapore General Hospital, Duke-NUS Medical School, The University of Texas MD Anderson Cancer Center, Michigan Center for Translational Pathology, University of Michigan–Ann Arbor5-Year Updates from the Pivotal Phase 2 Ponatinib PACE Trial: Efficacy, Safety and Landmark Analysis in Heavily Pretreated Patients with Chronic-Phase Chronic Myeloid Leukemia
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
